This grant is offered by a Health Research Department to support the evaluation of an enhanced telehealth program aiming to improve adherence and retention for HIV prevention (PrEP) and treatment (ART) medications. Utilizing a hybrid effectiveness-implementation research design, the program will assess the telehealth strategy’s effectiveness among clinically stable people with HIV and those at risk. It will also identify implementation facilitators and challenges for integrating these strategies into routine care. Furthermore, the grant focuses on evaluating the cost-effectiveness and impact of program enhancements, including multi-month prescriptions, biospecimen self-collection, and the use of specialized staff. This initiative specifically targets populations disproportionately affected by HIV, such as Black women with HIV, transgender women, and gay, bisexual, and other men who have sex with men.
Opportunity ID: 343629
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-PS-23-002 |
| Funding Opportunity Title: | Enhancing Telehealth Strategies to Support Retention and Adherence to Antiretroviral Therapy (ART) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 10, 2023 |
| Last Updated Date: | Jan 10, 2023 |
| Original Closing Date for Applications: | Mar 17, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Current Closing Date for Applications: | Mar 17, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Archive Date: | Apr 16, 2023 |
| Estimated Total Program Funding: | $3,600,000 |
| Award Ceiling: | $450,000 |
| Award Floor: | $350,000 |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal governments (Federally recognized) Small businesses Public and State controlled institutions of higher education State governments Public housing authorities/Indian housing authorities Private institutions of higher education For profit organizations other than small businesses Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | N/A |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to support the evaluation of the effectiveness of an enhanced telehealth program to improve adherence to HIV prevention and treatment medication, while also exploring the “implementability” of its practice into routine care. Specifically, the awardee will, via a hybrid effectiveness-implementation research design: 1) evaluate the effectiveness of an enhanced telehealth program for maintenance of HIV medication adherence among clinically stable people with HIV (PWH) and pre-exposure prophylaxis (PrEP) medication adherence for those at risk of HIV infection; and 2) identify potential implementation facilitators and challenges by evaluating the delivery of these strategies. Furthermore, the recipient will evaluate the cost and cost-effectiveness of providing telehealth to patients on antiretroviral therapy (ART) or PrEP, and evaluate program enhancements that will include, but may be not limited to, multi-month prescription refills, biospecimen sample self-collection, and the use of specialized staff such as community health workers and patient navigators. This enhanced telehealth program will focus on those disproportionately affected by HIV or at risk for HIV infection, including cis-gender Black or African American (hereafter referred to as Black) women with HIV, transgender women. and gay, bisexual and other men who have sex with men (hereafter referred to as MSM). |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jocelyn Patterson Mosley
fzp0@cdc.gov Email:fzp0@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 343629 Full Announcement-Full Announcement -> Foa_Content_of_RFA-PS-23-002.pdf
Folder 343629 Other Supporting Documents-Other Supporting Documents -> CDC Budget-Preparation-Guidance.pdf
Packages
| Agency Contact Information: | Jocelyn Patterson Mosley fzp0@cdc.gov Email: fzp0@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.084 | RFA-PS-23-002 | Enhancing Telehealth Strategies to Support Retention and Adherence to Antiretroviral Therapy (ART) | PKG00279175 | Jan 10, 2023 | Mar 17, 2023 | View |
Package 1
Mandatory forms
343629 RR_SF424_5_0-5.0.pdf
343629 PHS398_CoverPageSupplement_5_0-5.0.pdf
343629 RR_OtherProjectInfo_1_4-1.4.pdf
343629 RR_Budget_3_0-3.0.pdf
343629 PHS398_ResearchPlan_5_0-5.0.pdf
343629 RR_KeyPersonExpanded_4_0-4.0.pdf
343629 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
343629 PerformanceSite_4_0-4.0.pdf
Optional forms
343629 RR_SubawardBudget30_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
